Literature DB >> 36180781

T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all.

P Gaudeaux1, R D Moirangthem1, J Paillet1,2, M Martin-Corredera1,2, H Sadek2, P Rault2, A Joshi1, J Zuber1, T S Soheili2, O Negre2, I André3.   

Abstract

Entities:  

Year:  2022        PMID： 36180781     DOI： 10.1038/s41423-022-00927-5

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   22.096


× No keyword cloud information.
  11 in total

Review 1.  Induced Pluripotent Stem Cells Meet Genome Editing.

Authors:  Dirk Hockemeyer; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2016-05-05       Impact factor: 24.633

2.  Lentiviral Gene Therapy in HSCs Restores Lineage-Specific Foxp3 Expression and Suppresses Autoimmunity in a Mouse Model of IPEX Syndrome.

Authors:  Katelyn E Masiuk; Jennifer Laborada; Maria Grazia Roncarolo; Roger P Hollis; Donald B Kohn
Journal:  Cell Stem Cell       Date:  2019-01-10       Impact factor: 24.633

Review 3.  Chimeric Antigen Receptor Therapy.

Authors:  Carl H June; Michel Sadelain
Journal:  N Engl J Med       Date:  2018-07-05       Impact factor: 91.245

4.  3D-organoid culture supports differentiation of human CAR+ iPSCs into highly functional CAR T cells.

Authors:  Zhiqiang Wang; Helen P McWilliams-Koeppen; Hernan Reza; Julie R Ostberg; Wuyang Chen; Xiuli Wang; Christian Huynh; Vibhuti Vyas; Wen-Chung Chang; Renate Starr; Jamie R Wagner; Brenda Aguilar; Xin Yang; Xiwei Wu; Jinhui Wang; Wei Chen; Ellery Koelker-Wolfe; Christopher S Seet; Amélie Montel-Hagen; Gay M Crooks; Stephen J Forman; Christine E Brown
Journal:  Cell Stem Cell       Date:  2022-03-11       Impact factor: 25.269

5.  A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.

Authors:  Shoichi Iriguchi; Yutaka Yasui; Yohei Kawai; Suguru Arima; Mihoko Kunitomo; Takayuki Sato; Tatsuki Ueda; Atsutaka Minagawa; Yuta Mishima; Nariaki Yanagawa; Yuji Baba; Yasuyuki Miyake; Kazuhide Nakayama; Maiko Takiguchi; Tokuyuki Shinohara; Tetsuya Nakatsura; Masaki Yasukawa; Yoshiaki Kassai; Akira Hayashi; Shin Kaneko
Journal:  Nat Commun       Date:  2021-01-18       Impact factor: 14.919

6.  Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction.

Authors:  Baptiste Lamarthée; Armance Marchal; Soëli Charbonnier; Tifanie Blein; Juliette Leon; Emmanuel Martin; Lucas Rabaux; Katrin Vogt; Matthias Titeux; Marianne Delville; Hélène Vinçon; Emmanuelle Six; Nicolas Pallet; David Michonneau; Dany Anglicheau; Christophe Legendre; Jean-Luc Taupin; Ivan Nemazanyy; Birgit Sawitzki; Sylvain Latour; Marina Cavazzana; Isabelle André; Julien Zuber
Journal:  Nat Commun       Date:  2021-11-08       Impact factor: 14.919

Review 7.  CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications.

Authors:  Motahareh Arjomandnejad; Acadia L Kopec; Allison M Keeler
Journal:  Biomedicines       Date:  2022-01-26

Review 8.  Nature vs. nurture: FOXP3, genetics, and tissue environment shape Treg function.

Authors:  Arielle Raugh; Denise Allard; Maria Bettini
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

Review 9.  Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications.

Authors:  Michael Xavier Doss; Agapios Sachinidis
Journal:  Cells       Date:  2019-04-30       Impact factor: 6.600

10.  A DL-4- and TNFα-based culture system to generate high numbers of nonmodified or genetically modified immunotherapeutic human T-lymphoid progenitors.

Authors:  Ranjita Devi Moirangthem; Kuiying Ma; Sabrina Lizot; Anne Cordesse; Juliette Olivré; Corinne de Chappedelaine; Akshay Joshi; Agata Cieslak; John Tchen; Nicolas Cagnard; Vahid Asnafi; Antonio Rausell; Laura Simons; Julien Zuber; Tom Taghon; Frank J T Staal; Françoise Pflumio; Emmanuelle Six; Marina Cavazzana; Chantal Lagresle-Peyrou; Tayebeh Soheili; Isabelle André
Journal:  Cell Mol Immunol       Date:  2021-06-11       Impact factor: 11.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.